Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8668931
APP PUB NO 20130266647A1
SERIAL NO

13889441

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
ACTAVIS HOLDCO US INC400 INTERPACE PARKWAY MORRIS CORPORATE CENTER III PARSIPPANY NJ 07054

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Cardinal, John R Tamarac, US 16 734
Goldfarb, Robert I Golden Beach, US 7 23
Kositprapa, Unchalee Davie, US 21 361
Nangia, Avinash Weston, US 62 1261

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Sep 11, 2025
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00